SwastiChemEx: Pantheon buys Italian-based clinical engineering service provider IBSL

Saturday, 1 August 2015

Pantheon buys Italian-based clinical engineering service provider IBSL

Pantheon Holdco Ltd., doing business as the Pantheon Healthcare Group (Pantheon), has acquired Ingegneria Biomedica Santa Lucia S.p.A. (IBSL), a key Italy-based provider of clinical engineering and a large range of biomedical equipment services, from Gruppo Giglio.

Backed by the Permira Funds, the acquisition is part of Pantheon's continued geographic and modality growth strategy, which launched in August 2014 with the acquisition of Asteral Limited and MESA Group Holdings, two leading independent healthcare service companies operating within the European market. The combination created Europe's first integrated multi-vendor healthcare service platform for procuring, commissioning, managing and maintaining biomedical devices and diagnostic imaging equipment within public- and private-sector hospitals and clinics.

IBSL was born in 1997 from the entrepreneurial idea of Sergio and Bruno Giglio's long customer-centric experience with outsourcing options for heating systems. Their biomedical business quickly grew to become one of the leading clinical engineering service providers in Italy, providing direct maintenance to biomedical systems within hospitals and clinics across Italy. In the ensuing years, IBSL integrated further management expertise and technical competences through the acquisition of D&D Med. Com., Ra.se.co, Gidea Alta Tecnologia and Te.Mo.Sa, further strengthening its position in clinical engineering and expanding its reach in the sector of diagnostic imaging equipment and outsourcing services.

No comments:

Post a Comment